DIFFERENTIAL SPATIOTEMPORAL REGULATION OF LACTOFERRIN AND PROGESTERONE-RECEPTOR GENES IN THE MOUSE UTERUS BY PRIMARY ESTROGEN, CATECHOL ESTROGEN, AND XENOESTROGEN
Sk. Das et al., DIFFERENTIAL SPATIOTEMPORAL REGULATION OF LACTOFERRIN AND PROGESTERONE-RECEPTOR GENES IN THE MOUSE UTERUS BY PRIMARY ESTROGEN, CATECHOL ESTROGEN, AND XENOESTROGEN, Endocrinology, 139(6), 1998, pp. 2905-2915
Many xenobiotics are considered reproductive toxins because of their a
bility to interact with the nuclear estrogen receptors (ER alpha and E
R beta). However, there is evidence that these xenobiotics can regulat
e gene expression in the reproductive targets by mechanisms that do no
t involve these ERs. To examine this further, we compared the effects
of estrogenic (o,p'-DDT rophenyl)-1-(p-chlorophenyl)2,2,2-trichloroeth
ane] and Kepone, chlordecone) and nonestrogenic (p,p'-DDD) [1,1-dichlo
ro-2,2-bis(p-chlorophenyl)ethane], a metabolite of p,p'-DDT) xenobioti
cs with those of 17 beta-estradiol (E-2) and 4-hydroxyestradiol-17 bet
a (4-OH-E-2), a catechol metabolite of E-2, on uterine expression of l
actoferrin (LF) and progesterone receptor (PR). These genes are estrog
en responsive in the mouse uterus. Normally, LF is expressed in the ut
erine epithelium, whereas PR is expressed in both the epithelium and s
troma in response to estrogenic stimulation. Ovariectomized mice were
injected with xenobiotics (7.5 mg/kg), E-2 (10 mu g/kg), 4-OH-E-2 (10
mu g/kg), or the vehicle (oil, 0.1 ml/mouse), and uterine tissues were
processed for Northern blot and in situ hybridization. The pure antie
strogen ICI-182780 (ICI; 1 or 20 mg/kg) was used to interfere with est
rogenic responses that were associated with the ERs. The results of No
rthern and in situ hybridization demonstrated increased uterine levels
of PR and LF messenger RNAs (mRNAs) by all of these xenobiotics, but
quantitatively the responses were much lower than those induced by E-2
or 4-OH-E-2. The results further showed that the E-2-inducible epithe
lial LF mRNA accumulation was markedly abrogated by pretreatment with
ICI (20 mg/kg). In contrast, this treatment retained the epithelial ex
pression of PR mRNA, but down-regulated the stromal expression. In con
trast, ICI had negligible effects on LF and PR mRNA responses to 4-OH-
E-2, indicating that this catechol estrogen exerted its effects primar
ily via a mechanism(s) other than the ERs. The heightened accumulation
of LF mRNA in the epithelium in response to Kepone and o,p'-DDT was a
lso severely compromised by pretreatment with ICI, but this antiestrog
en had little effect on responses to p,p'-DDD. Similar to E-2, Kepone
increased the expression of PR mRNA in both uterine epithelium and str
oma. However, pretreatment with ICI decreased stromal cell expression,
whereas epithelial cell expression remained unaltered or increased. T
hese responses were not noted in mice treated with o,p'-DDT or p,p'-DD
D. Collectively, the results demonstrate that catechol estrogens or xe
nobiotics can alter uterine expression of estrogen-responsive genes by
mechanisms that are not totally mediated by the classical nuclear ERs
, and these alterations are cell type specific. We conclude that an in
teraction of a compound with the nuclear ER alpha and/or ER beta is no
t an absolute requirement for producing specific estrogen-like effects
in the reproductive target tissues.